These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10037385)

  • 21. Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries.
    Fourcade RO; Théret N; Taïeb C;
    BJU Int; 2008 May; 101(9):1111-8. PubMed ID: 18279447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of the impact of CTMH guidelines on the management of benign prostatic hyperplasia].
    Lebdai S; Rahmène Azzouzi A; Delongchamps NB; Benchikh A; Campeggi A; Cornu JN; Dumonceau O; Faix A; Fourmarier M; Haillot O; Lukacs B; Mathieu R; Misrai V; Robert G; de La Taille A; Descazeaud A
    Prog Urol; 2015 Jan; 25(1):47-53. PubMed ID: 25453357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Benign prostatic hyperplasia; recommendations for transmural care. Working Group, Dutch College of General Practitioners and Netherlands College of Urologists].
    Klomp ML; Rosmalen CF; Romeijnders AC; Oosterhof GO; Schlatmann TJ
    Ned Tijdschr Geneeskd; 1998 Nov; 142(47):2563-8. PubMed ID: 10028352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of the urologist and nurse from the perspective of patients with prostate cancer receiving luteinizing hormone-releasing hormone analogue therapy.
    Lebret T; Bouregba A
    BJU Int; 2008 Nov; 102(10):1419-24. PubMed ID: 18549431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.
    Suzuki H; Yano M; Awa Y; Nakatsu H; Egoshi K; Mikami K; Ota S; Okano T; Hamano S; Ohki T; Furuya Y; Ichikawa T
    Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Benign prostatic hyperplasia (BPH): prevalence in general practice and practical approach of French general practitioners. Results of a study based on 17,953 patients].
    Costa P; Ben Naoum K; Boukaram M; Wagner L; Louis JF
    Prog Urol; 2004 Feb; 14(1):33-9. PubMed ID: 15098749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status.
    Jacobsen SJ; Jacobson DJ; Girman CJ; Roberts RO; Rhodes T; Guess HA; Lieber MM
    J Urol; 1999 Oct; 162(4):1301-6. PubMed ID: 10492184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The benign prostatic hyperplasia registry and patient survey: study design, methods and patient baseline characteristics.
    Roehrborn CG; Nuckolls JG; Wei JT; Steers W;
    BJU Int; 2007 Oct; 100(4):813-9. PubMed ID: 17822462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of benign prostatic hyperplasia and occurrence of prostatic surgery and acute urinary retention: a population-based cohort study in the Netherlands.
    Souverein PC; van Riemsdijk MM; de la Rosette JJ; Opdam PC; Leufkens HG
    Eur Urol; 2005 Apr; 47(4):505-10. PubMed ID: 15774250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Practice patterns in vasectomy reversal surgery: results of a questionnaire study among practicing urologists.
    Crain DS; Roberts JL; Amling CL
    J Urol; 2004 Jan; 171(1):311-5. PubMed ID: 14665903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of the International Prostate Symptom Score bother question with the Benign Prostatic Hyperplasia Impact Index in a clinical practice setting.
    O'Leary MP; Wei JT; Roehrborn CG; Miner M;
    BJU Int; 2008 Jun; 101(12):1531-5. PubMed ID: 18445080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dental screening and referral of young children by pediatric primary care providers.
    dela Cruz GG; Rozier RG; Slade G
    Pediatrics; 2004 Nov; 114(5):e642-52. PubMed ID: 15520094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function: a prospective study.
    Arai Y; Aoki Y; Okubo K; Maeda H; Terada N; Matsuta Y; Maekawa S; Ogura K
    J Urol; 2000 Oct; 164(4):1206-11. PubMed ID: 10992367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1999 American Urological Association Gallup Survey: changes in physician practice patterns, treatment of incontinence and bladder cancer, and impact of managed care.
    O'Leary MP; Gee WF; Holtgrewe HL; Blute ML; Cooper TP; Miles BJ; Nellans RE; Thomas R; Painter MR; Meyer JJ; Naslund MJ; Gormley EA; Blizzard R; Fenninger RB
    J Urol; 2000 Oct; 164(4):1311-6. PubMed ID: 10992396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences between urologists in the United States and Canada in the approach to prostate cancer.
    Fleshner N; Rakovitch E; Klotz L
    J Urol; 2000 May; 163(5):1461-6. PubMed ID: 10751858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study on patients with benign prostate hyperplasia treated by the therapeutic regimen of watchful waiting during a twenty-four-month follow-up period].
    Zhang YG; Wang JY; Liu M; Xu J; Wu JY; Xin Y; Wan B; Wei D; Zhu SC; Zeng P
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):611-3. PubMed ID: 19040049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physicians' preferences and expectations in traumatic brain injury rehabilitation--results of a case-based questionnaire survey.
    Hasenbein U; Kuss O; Bäumer M; Schert C; Schneider H; Wallesch CW
    Disabil Rehabil; 2003 Feb; 25(3):136-42. PubMed ID: 12648003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The trend of managing prostate cancer in Taiwan.
    Wong WY; Chen SC; Chueh SC; Chen J
    Int J Urol; 2004 Jul; 11(7):510-4. PubMed ID: 15242360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [How to plan the treatment of prostatic adenoma today?].
    Chatelain C; Conort P; Chartier-Kastler E; Boyer C; Bianchini JM; Richard F
    Bull Acad Natl Med; 1999; 183(3):615-34; discussion 634-7. PubMed ID: 10437290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incontinence related to management of benign prostatic hypertrophy.
    Han E; Black LK; Lavelle JP
    Am J Geriatr Pharmacother; 2007 Dec; 5(4):324-34. PubMed ID: 18179990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.